J.F. Nishimuta, M.E. Levenston  Osteoarthritis and Cartilage 

Slides:



Advertisements
Similar presentations
Efficacy of ultrasound therapy for the management of knee osteoarthritis: a systematic review with meta-analysis A. Loyola-Sánchez, J. Richardson, N.J.
Advertisements

Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering  J.K. Mouw, M.S., N.D. Case, Ph.D., R.E. Guldberg,
CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes  T. Fujisawa, Ph.D., D.D.S.,
Moderate dynamic compression inhibits pro-catabolic response of cartilage to mechanical injury, tumor necrosis factor-α and interleukin-6, but accentuates.
Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading  E.J. Vanderploeg, Ph.D., C.G.
A. Hennerbichler, M. D. , F. T. Moutos, M. S. , D. Hennerbichler, M. D
The epidemiology and impact of pain in osteoarthritis
A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair  M.B. Schmidt, Ph.D.,
Reduced response of human meniscal cells to Osteogenic Protein 1 during osteoarthritis and pro-inflammatory stimulation  K.S. Vanderman, R.F. Loeser,
P.-S. Hsu, H.-H. Lin, C.-R. Li, W.-S. Chung 
M. Akagi, M. D. , Ph. D. , A. Ueda, M. D. , T. Teramura, Ph. D. , S
A.J. McGregor, B.G. Amsden, S.D. Waldman  Osteoarthritis and Cartilage 
Changes in social isolation and loneliness following total hip and knee arthroplasty: longitudinal analysis of the English Longitudinal Study of Ageing.
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Zonal differences in meniscus matrix turnover and cytokine response
Proteoglycan synthesis in bovine articular cartilage explants exposed to different low- frequency low-energy pulsed electromagnetic fields  M. De Mattei,
Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives  Y. Henrotin  Osteoarthritis and Cartilage 
Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis  D.D. Greenberg, M.D., A. Stoker, Ph.D., S. Kane,
Cartilage degradation independent of MMP/aggrecanases
Glucosamine reduces anabolic as well as catabolic processes in bovine chondrocytes cultured in alginate  E.J. Uitterlinden, M.D., H. Jahr, Ph.D., J.L.M.
The differences on extracellular matrix among each portion of meniscus
Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review  J.C. Fernández López, M.D., Ph.D.,
Osteoarthritis pain mechanisms: basic studies in animal models
A.W. Palmer, C.G. Wilson, E.J. Baum, M.E. Levenston 
Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis  Y. Li, Y. Wang,
Time to be positive about negative data?
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results.
Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in.
J. Avouac, M.D., L. Gossec, M.D., M. Dougados, M.D. 
A stable isotope method for the simultaneous measurement of matrix synthesis and cell proliferation in articular cartilage in vivo  K.W. Li, S.A. Siraj,
Stem cell therapy for human cartilage defects: a systematic review
S. Sonne-Holm, M.D., Dr. Sci., S. Jacobsen, M.D. 
N.D. Miljkovic, M.D., Ph.D., G.M. Cooper, Ph.D., K.G. Marra, Ph.D. 
B. Vafaeian, S. Adeeb, M. El-Rich, J. Jaremko 
Risk factors associated with reduced work productivity among people with chronic knee pain  M. Agaliotis, M. Fransen, L. Bridgett, L. Nairn, M. Votrubec,
J. Ranstam  Osteoarthritis and Cartilage 
L. C. Davies, B. Sc. , Ph. D. , E. J. Blain, B. Sc. , Ph. D. , B
Effectiveness of thermal and athermal short-wave diathermy for the management of knee osteoarthritis: a systematic review and meta-analysis  Y. Laufer,
Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress  L Lippiello  Osteoarthritis.
Utilization rates of hip arthroplasty in OECD countries
M. Hufeland, M. Schünke, A.J. Grodzinsky, J. Imgenberg, B. Kurz 
A graphic user interface for the evaluation of knee osteoarthritis (GEKO): an open- source tool for histological grading  H.E. Kloefkorn, B.Y. Jacobs,
Who should have a joint replacement? A plea for more ‘phronesis’
Osteoarthritis and Cartilage
S. Abubacker, H.O. Ham, P.B. Messersmith, T.A. Schmidt 
Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs  J.T. Connelly, Ph.D., C.G. Wilson,
Effect of a glucosamine derivative on impact-induced chondrocyte apoptosis in vitro. A preliminary report  C.A.M. Huser, Ph.D., M.E. Davies, Ph.D.  Osteoarthritis.
Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β- stimulated chondrocytes – study in hypoxic alginate bead cultures 
I.C. Olsen, T.K. Kvien, T. Uhlig  Osteoarthritis and Cartilage 
A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee  T.J. Schnitzer, J.A. Marks  Osteoarthritis.
Photochemical approaches for bonding of cartilage tissues
D.J. Hunter  Osteoarthritis and Cartilage 
Cartilage growth and remodeling: modulation of balance between proteoglycan and collagen network in vitro with β-aminopropionitrile  A. Asanbaeva, Ph.D.,
B. Zielinska, M. Killian, M. Kadmiel, M. Nelsen, T.L. Haut Donahue 
Limited effects of exercises in people with hand osteoarthritis: results from a randomized controlled trial  N. Østerås, K.B. Hagen, M. Grotle, A.-L.
K. -C. Wang, E. Kwan, K. Aris, T. T. Egelhoff, A. I. Caplan, J. F
C. Ratzlaff, M. Koehoorn, J. Cibere, J. Kopec 
Development and preliminary evaluation of the OsteoArthritis Questionnaire (OA- Quest): a psychometric study  L. Busija, R. Buchbinder, R.H. Osborne  Osteoarthritis.
N. Frey, T. Hügle, S.S. Jick, C.R. Meier, J. Spoendlin 
Osteoarthritis year 2012 in review: biology
Location-specific hip joint space width for progression of hip osteoarthritis – Data from the Osteoarthritis Initiative  C. Ratzlaff, C. Van Wyngaarden,
J.F. Nishimuta, M.E. Levenston  Osteoarthritis and Cartilage 
Systematic review of the impact of osteoarthritis on health outcomes for comorbid disease in older people  L. Parkinson, D.L. Waters, L. Franck  Osteoarthritis.
Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage  S. Clockaerts,
Osteoarthritis year in review 2016: mechanics
K. -C. Wang, E. Kwan, K. Aris, T. T. Egelhoff, A. I. Caplan, J. F
Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage 
M. Doherty, P. Dieppe  Osteoarthritis and Cartilage 
Central and peripheral region tibial plateau chondrocytes respond differently to in vitro dynamic compression  S.L. Bevill, P.L. Briant, M.E. Levenston,
General Information Osteoarthritis and Cartilage
Presentation transcript:

Meniscus is more susceptible than cartilage to catabolic and anti-anabolic effects of adipokines  J.F. Nishimuta, M.E. Levenston  Osteoarthritis and Cartilage  Volume 23, Issue 9, Pages 1551-1562 (September 2015) DOI: 10.1016/j.joca.2015.04.014 Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Initial effects of adipokines on sGAG release. sGAG contents of conditioned media from cartilage (A–B) and meniscus (C–D) explants treated with adipokines for 22 h. Note the difference in scaling between cartilage and meniscus. *P < 0.05 relative to tissue-matched controls, #P < 0.05 relative to 0.02 μg/ml treatment, %P < 0.05 relative to 0.20 μg/ml treatment, †P < 0.05 relative to cartilage at the same treatment and dose. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Effects of sustained adipokine exposure on sGAG release. 48-hour sGAG release to media from cartilage (left column) and meniscus (right column) explants treated with adipokines for 8 days. *P < 0.05 relative to tissue-matched controls, #P < 0.05 relative to 0.02 μg/ml treatment, †P < 0.05 relative to cartilage at the same treatment and dose, ˆP < 0.05 relative to cartilage for some groups. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 Initial effects of adipokines on nitrite release. Nitrite content of conditioned media from cartilage (A–B) and meniscus (C–D) explants treated with adipokines for 22 h. Note the difference in scaling between cartilage and meniscus. *P < 0.05 relative to tissue-matched controls, #P < 0.05 relative to 0.02 μg/ml treatment, %P < 0.05 relative to 0.20 μg/ml treatment, †P < 0.05 relative to cartilage at the same treatment and dose. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 Effects of sustained adipokine exposure on nitrite release. 48-hour nitrite levels in conditioned media from cartilage (left column) and meniscus (right column) explants treated with adipokines for 8 days. Note the differences in scaling. *P < 0.05 relative to tissue-matched controls, #P < 0.05 relative to 0.02 μg/ml treatment, %P < 0.05 relative to 0.20 μg/ml treatment, †P < 0.05 relative to cartilage at the same treatment and dose, ˆP < 0.05 relative to cartilage for some groups. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Initial effects of adipokines on explant sGAG content. sGAG content of cartilage (A–B) and meniscus (C–D) explants treated with adipokines for 22 h. Note difference in vertical axes between cartilage and meniscus. #P < 0.05 relative to 0.02 μg/ml treatment, †P < 0.05 relative to cartilage. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Effect of sustained adipokine exposure on explant sGAG content. sGAG content of cartilage (A–B) and meniscus (C–D) explants treated with adipokines for 22 h. Note the difference in scaling between cartilage and meniscus. *P < 0.05 relative to controls. #P < 0.05 relative to 0.02 μg/ml treatment, †P < 0.05 relative to cartilage. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 7 Initial effects of adipokines on incorporation rates. Protein (3H-proline, A-D) and sGAG (35S-sulfate, E-H) incorporation rates of cartilage (A-B, E-F) and meniscus (C-D, G-H) explants over the first 22 h of culture with adipokines. Note the difference in scaling between cartilage and meniscus. *P < 0.05 relative to tissue-matched controls unless otherwise indicated, #P < 0.05 relative to 0.02 μg/ml treatment, %P < 0.05 relative to 0.20 μg/ml treatment, †P < 0.05 relative to cartilage tissue. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 8 Effects of sustained adipokine exposure on incorporation rates. Protein (3H-proline, A–D) and sGAG (35S-sulfate, E–H) incorporation rates of cartilage (A–B, E–F) and meniscus (C–D, G–H) explants over the final 22 h of 9-day cultures with adipokines. Note the difference in scaling between cartilage and meniscus. *P < 0.05 relative to tissue-matched controls, #P < 0.05 relative to 0.02 μg/ml treatment, †P < 0.05 relative to cartilage tissue. Osteoarthritis and Cartilage 2015 23, 1551-1562DOI: (10.1016/j.joca.2015.04.014) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions